TY - JOUR
T1 - Setting Thresholds to Varying Blood Pressure Monitoring Intervals Differentially Affects Risk Estimates Associated With White-Coat and Masked Hypertension in the Population
AU - Asayama, Kei
AU - Thijs, Lutgarde
AU - Li, Yan
AU - Gu, Yu-Mei
AU - Hara, Azusa
AU - Liu, Yan-Ping
AU - Zhang, Zhenyu
AU - Wei, Fang-Fei
AU - Lujambio, Ines
AU - Mena, Luis J.
AU - Boggia, Jose
AU - Hansen, Tine W.
AU - Bjoerklund-Bodegard, Kristina
AU - Nomura, Kyoko
AU - Ohkubo, Takayoshi
AU - Jeppesen, Jorgen
AU - Torp-Pedersen, Christian
AU - Dolan, Eamon
AU - Stolarz-Skrzypek, Katarzyna
AU - Malyutina, Sofia
AU - Casiglia, Edoardo
AU - Nikitin, Yuri
AU - Lind, Lars
AU - Luzardo, Leonella
AU - Kawecka-Jaszcz, Kalina
AU - Sandoya, Edgardo
AU - Filipovsky, Jan
AU - Maestre, Gladys E.
AU - Wang, Jiguang
AU - Imai, Yutaka
AU - Franklin, Stanley S.
AU - O'Brien, Eoin
AU - Staessen, Jan A.
PY - 2014/11
Y1 - 2014/11
N2 - Outcome-driven recommendations about time intervals during which ambulatory blood pressure should be measured to diagnose white-coat or masked hypertension are lacking. We cross-classified 8237 untreated participants (mean age, 50.7 years; 48.4% women) enrolled in 12 population studies, using >= 140/>= 90, >= 130/>= 80, >= 135/>= 85, and >= 120/>= 70 mm Hg as hypertension thresholds for conventional, 24-hour, daytime, and nighttime blood pressure. White-coat hypertension was hypertension on conventional measurement with ambulatory normotension, the opposite condition being masked hypertension. Intervals used for classification of participants were daytime, nighttime, and 24 hours, first considered separately, and next combined as 24 hours plus daytime or plus nighttime, or plus both. Depending on time intervals chosen, white-coat and masked hypertension frequencies ranged from 6.3% to 12.5% and from 9.7% to 19.6%, respectively. During 91 046 person-years, 729 participants experienced a cardiovascular event. In multivariable analyses with normotension during all intervals of the day as reference, hazard ratios associated with white-coat hypertension progressively weakened considering daytime only (1.38; P=0.033), nighttime only (1.43; P=0.0074), 24 hours only (1.21; P=0.20), 24 hours plus daytime (1.24; P=0.18), 24 hours plus nighttime (1.15; P=0.39), and 24 hours plus daytime and nighttime (1.16; P=0.41). The hazard ratios comparing masked hypertension with normotension were all significant (P
AB - Outcome-driven recommendations about time intervals during which ambulatory blood pressure should be measured to diagnose white-coat or masked hypertension are lacking. We cross-classified 8237 untreated participants (mean age, 50.7 years; 48.4% women) enrolled in 12 population studies, using >= 140/>= 90, >= 130/>= 80, >= 135/>= 85, and >= 120/>= 70 mm Hg as hypertension thresholds for conventional, 24-hour, daytime, and nighttime blood pressure. White-coat hypertension was hypertension on conventional measurement with ambulatory normotension, the opposite condition being masked hypertension. Intervals used for classification of participants were daytime, nighttime, and 24 hours, first considered separately, and next combined as 24 hours plus daytime or plus nighttime, or plus both. Depending on time intervals chosen, white-coat and masked hypertension frequencies ranged from 6.3% to 12.5% and from 9.7% to 19.6%, respectively. During 91 046 person-years, 729 participants experienced a cardiovascular event. In multivariable analyses with normotension during all intervals of the day as reference, hazard ratios associated with white-coat hypertension progressively weakened considering daytime only (1.38; P=0.033), nighttime only (1.43; P=0.0074), 24 hours only (1.21; P=0.20), 24 hours plus daytime (1.24; P=0.18), 24 hours plus nighttime (1.15; P=0.39), and 24 hours plus daytime and nighttime (1.16; P=0.41). The hazard ratios comparing masked hypertension with normotension were all significant (P
KW - ambulatory blood pressure monitoring
KW - cardiovascular risk
KW - masked hypertension
KW - population science
KW - white-coat hypertension
U2 - 10.1161/HYPERTENSIONAHA.114.03614
DO - 10.1161/HYPERTENSIONAHA.114.03614
M3 - Article
C2 - 25135185
SN - 0194-911X
VL - 64
SP - 935
EP - 942
JO - Hypertension
JF - Hypertension
IS - 5
ER -